Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIndivior Regulatory News (INDV)

  • There is currently no data for INDV

Block listing Interim Review

9 Nov 2020 08:48

RNS Number : 6531E
Indivior PLC
09 November 2020
 

BLOCK LISTING SIX MONTHLY RETURN

 

Date: November 9, 2020

 

Name of applicant:

INDIVIOR PLC

Name of scheme:

LONG-TERM INCENTIVE PLAN

Period of return:

From:

MAY 10, 2020

To:

NOVEMBER 9, 2020

Balance of unallotted securities under scheme(s) from previous return:

6,360,554 ORDINARY SHARES OF US$0.10

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

NIL

Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

19,702

Equals: Balance under scheme(s) not yet issued/allotted at end of period:

6,340,852 ORDINARY SHARES OF US$0.10

 

Name of contact:

KATHRYN HUDSON

Telephone number of contact:

01753 423 940

 

 

Date: November 9, 2020

 

Name of applicant:

INDIVIOR PLC

Name of scheme:

UK SAVINGS RELATED SHARE OPTION PLAN

Period of return:

From:

MAY 10, 2020

To:

NOVEMBER 9, 2020

Balance of unallotted securities under scheme(s) from previous return:

1,000,000 ORDINARY SHARES OF US$0.10

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

NIL

Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

NIL

Equals: Balance under scheme(s) not yet issued/allotted at end of period:

1,000,000 ORDINARY SHARES OF US$0.10

 

Name of contact:

KATHRYN HUDSON

Telephone number of contact:

01753 423 940

 

 

Date: November 9, 2020

 

Name of applicant:

INDIVIOR PLC

Name of scheme:

U.S. EMPLOYEE STOCK PURCHASE PLAN

Period of return:

From:

MAY 10, 2020

To:

NOVEMBER 9, 2020

Balance of unallotted securities under scheme(s) from previous return:

780,891 ORDINARY SHARES OF US$0.10

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

5,000,000

Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

1,048,667

Equals: Balance under scheme(s) not yet issued/allotted at end of period:

4,732,224 ORDINARY SHARES OF US$0.10

 

Name of contact:

KATHRYN HUDSON

Telephone number of contact:

01753 423940

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BLRBLBPTMTIMMAM
Date   Source Headline
28th Nov 20227:00 amRNSTransaction in Own Shares
25th Nov 20227:00 amRNSTransaction in Own Shares
24th Nov 20227:00 amRNSTransaction in Own Shares
23rd Nov 20224:25 pmRNSHolding(s) in Company
23rd Nov 20227:00 amRNSTransaction in Own Shares
22nd Nov 20222:36 pmRNSHolding(s) in Company
22nd Nov 20222:32 pmRNSHolding(s) in Company
22nd Nov 20227:00 amRNSTransaction in Own Shares
21st Nov 20227:00 amRNSTransaction in Own Shares
18th Nov 20227:00 amRNSTransaction in Own Shares
17th Nov 20227:00 amRNSTransaction in Own Shares
16th Nov 20227:00 amRNSTransaction in Own Shares
15th Nov 202210:00 amRNSDirector Declaration
15th Nov 20227:00 amRNSTransaction in Own Shares
14th Nov 20227:00 amRNSIndivior To Acquire Opiant Pharmaceuticals
14th Nov 20227:00 amRNSTransaction in Own Shares
11th Nov 20227:00 amRNSTransaction in Own Shares
10th Nov 20227:00 amRNSTransaction in Own Shares
9th Nov 20224:46 pmRNSBlock listing Interim Review
9th Nov 20228:30 amRNSIndivior to Host Capital Markets Day December 7
9th Nov 20227:00 amRNSTransaction in Own Shares
8th Nov 202210:48 amRNSHolding(s) in Company
8th Nov 20227:00 amRNSTransaction in Own Shares
7th Nov 20227:00 amRNSTransaction in Own Shares
4th Nov 20227:00 amRNSTransaction in Own Shares
3rd Nov 20227:00 amRNSTransaction in Own Shares
2nd Nov 20227:00 amRNSTransaction in Own Shares
1st Nov 20229:28 amRNSTotal Voting Rights
1st Nov 20229:08 amRNSIndivior to Participate in Conference
1st Nov 20227:00 amRNSTransaction in Own Shares
31st Oct 20227:00 amRNSTransaction in Own Shares
28th Oct 20227:00 amRNSTransaction in Own Shares
27th Oct 20228:07 amRNS3rd Quarter Results
27th Oct 20227:00 amRNSTransaction in Own Shares
26th Oct 20223:26 pmRNSHolding(s) in Company
26th Oct 20227:00 amRNSTransaction in Own Shares
25th Oct 202212:24 pmRNSHolding(s) in Company
25th Oct 202212:17 pmRNSHolding(s) in Company
25th Oct 20227:00 amRNSTransaction in Own Shares
24th Oct 20227:00 amRNSTransaction in Own Shares
21st Oct 20224:04 pmRNSHolding(s) in Company
21st Oct 20227:00 amRNSTransaction in Own Shares
20th Oct 20227:00 amRNSTransaction in Own Shares
19th Oct 20227:27 amRNSTransaction in Own Shares
18th Oct 20227:00 amRNSTransaction in Own Shares
17th Oct 20227:00 amRNSTransaction in Own Shares
14th Oct 20227:00 amRNSTransaction in Own Shares
13th Oct 202211:41 amRNSHolding(s) in Company
13th Oct 20227:00 amRNSIndivior updates Board Succession Plans
13th Oct 20227:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.